Biophasic availability of ophthalmic carbachol. I. Mechanisms of cationic polymer- and surfactant-promoted miotic activity.
D000276:Adjuvants, Immunologic; D000818:Animals; D001082:Aqueous Humor / Q000187:drug effects; D001548:Benzalkonium Compounds / Q000494:pharmacology; D001702:Biopharmaceutics; D002217:Carbachol / Q000494:pharmacology*; D003911:Dextrans / Q000494:pharmacology; D005123:Eye / Q000187:drug effects; D008916:Miotics / Q000494:pharmacology*; D009883:Ophthalmic Solutions / Q000494:pharmacology*; D014677:Pharmaceutical Vehicles; D011108:Polymers; D011817:Rabbits; D013501:Surface-Active Agents; D013997:Time Factors
D000276:Adjuvants, Immunologic; D001548:Benzalkonium Compounds; D003911:Dextrans; D008916:Miotics; D009883:Ophthalmic Solutions; D014677:Pharmaceutical Vehicles; D011108:Polymers; D013501:Surface-Active Agents; D002217:Carbachol